Welcome to iChemical.com!

In the below part, please select the country you want us to ship to: Please note that once you've selected a shipping country, all pricing information on our website will be automatically updated to include door-to-door shipping to the country you specified.

    OK
    Get Quote Login
    1009335-43-6

    Catalog No. EBD2155420

    CAS 1009335-43-6

    Name 1,1-Dimethylethyl N-[(3R,5R)-5-(hydroxymethyl)-3-pyrrolidinyl]carbamate

    Get Quote
    Basic Information

    Synonyms: (2R,4R)-2-Hydroxymethyl-4-BOC-aminopyrrolidineHCl Carbamicacid,N-[(3R,5R)-5-(hydroxymethyl)-3-pyrrolidinyl]-,1,1-dimethylethylester

    Molecular Formula: C10H20N2O3

    Molecular Weight: 216.28

    MDL Number: MFCD11042660

    Categories: Medicinal Chemistry > Pharmaceutical Intermediates > Heterocyclic Intermediates Medicinal Chemistry > Biochemicals and Life Science Reagents > Peptides and Peptidomimetics

    Product Description:
    N-[(3R,5R)-5-(Hydroxymethyl)-3-pyrrolidinyl]carbamic acid tert-butyl ester is a chiral pyrrolidine derivative characterized by a hydroxymethyl group and a tert-butoxycarbonyl (Boc) protected amine. This specific stereochemistry ((3R,5R)) is crucial for its intended applications. This compound serves as a key chiral building block in pharmaceutical synthesis. Its primary application is as a sophisticated intermediate for the preparation of complex drug candidates, particularly those targeting infectious diseases. It is notably utilized in the synthesis of novel antibacterial agents, such as certain advanced oxazolidinone antibiotics designed to combat drug-resistant bacterial strains. The pyrrolidine scaffold with these functional handles allows for further elaboration into potent pharmacophores. The presence of both a protected amine and a hydroxymethyl group makes it a versatile precursor for constructing peptidomimetics and other bioactive molecules. Its use underscores the importance of stereochemically defined heterocyclic intermediates in modern medicinal chemistry for developing new therapeutic entities.
    Physical Properties
    mg g kg ml l t